Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib (2025)
- Authors:
- USP affiliated authors: CHAMMAS, ROGER - FM ; ENGLER, SILVYA STUCHI MARIA - FCF
- Unidades: FM; FCF
- DOI: 10.3390/ijms26062675
- Subjects: MELANOMA; PROTEÍNAS QUINASES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Molecular Sciences
- ISSN: 1661-6596
- Volume/Número/Paginação/Ano: v. 26, p. 1-23, 2025
- Este artigo NÃO possui versão em acesso aberto
-
ABNT
SOUZA, Laura Francisca Leite do Prado de et al. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib. International Journal of Molecular Sciences, v. 26, p. 1-23, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/ijms26062675. Acesso em: 07 mar. 2026. -
APA
Souza, L. F. L. do P. de, Ferraz, L. S., Tortelli Junior, T. C., Ribeiro, C. A. J., Amaral, D. T., Arruda, D. C., et al. (2025). Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib. International Journal of Molecular Sciences, 26, 1-23. doi:10.3390/ijms26062675 -
NLM
Souza LFL do P de, Ferraz LS, Tortelli Junior TC, Ribeiro CAJ, Amaral DT, Arruda DC, Oliveira EA de, Chammas R, Maria-Engler SS, Rodrigues T. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-23.[citado 2026 mar. 07 ] Available from: https://dx.doi.org/10.3390/ijms26062675 -
Vancouver
Souza LFL do P de, Ferraz LS, Tortelli Junior TC, Ribeiro CAJ, Amaral DT, Arruda DC, Oliveira EA de, Chammas R, Maria-Engler SS, Rodrigues T. Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant melanoma to vemurafenib [Internet]. International Journal of Molecular Sciences. 2025 ; 26 1-23.[citado 2026 mar. 07 ] Available from: https://dx.doi.org/10.3390/ijms26062675 - Expression analysis of KIAA0090, a new gene with evidence involvement in cancer
- A novel gene linked to melanoma progression
- Exploiting paradoxical activation of oncogenic MAPK signaling by targeting mitochondria to sensitize NRAS mutant‐melanoma to vemurafenib
- Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool
- Resenha sem título próprio
- Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression
- Oxidative stress triggered by apigenin induces apoptosis in a comprehensive panel of human cervical cancer-derived cell lines
- Estudo destaca potencial do jucá contra rugas e manchas na pele
- Organotypic models in drug development tumor models and cancer systems biology for the investigation of anticancer drugs and resistance development
- Assessing the effects of advanced glycation end products in the skin
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3245013.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
